FDA Adverse Event Injury Summary report: N

SIMPLEX P FULL DOSE 1 PACK

MDR report key: 3002502 · Received March 13, 2013

Report

Report Number
0002249697-2013-00970
Event Type
Injury
Date Received
March 13, 2013
Date of Event
January 22, 2013
Report Date
February 21, 2013
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
LOD
PMA / PMN Number
K062553
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

AN EVENT REGARDING IMPLANT LOOSENING INVOLVING SIMPLEX BONE CEMENT WAS REPORTED. DEVICE HISTORY REVIEW INDICATES THERE WERE NO REPORTED DISCREPANCIES FOR THE REFERENCED LOT. COMPLAINT HISTORY REVIEW INDICATES THERE WERE NO OTHER EVENTS FOR THE REPORTED LOT. THE EXACT CAUSE OF THE EVENT COULD NOT BE DETERMINED BECAUSE FURTHER INFORMATION SUCH AS PRE- AND POST-OPERATIVE X-RAYS AND THE PRIMARY OPERATIVE REPORT AS WELL AS PATIENT HISTORY, FOLLOW-UP NOTES, AND IMPLANT IDENTIFICATION INFORMATION ARE NEEDED TO COMPLETE THE INVESTIGATION FOR DETERMINING ROOT CAUSE. THE EVENT WAS NOT CONFIRMED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION HAS BEEN REQUESTED AND IF RECEIVED WILL BE PROVIDED IN A SUPPLEMENTAL REPORT. NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD REVISION SURGERY OF A LEFT TOTAL KNEE ARTHROPLASTY. THERE WAS EITHER DISASSOCIATION BETWEEN THE CEMENT AND BASEPLATE OR CEMENT FAILURE WITH BASEPLATE, NECESSITATING RE-OPERATION TO REPLACE BOTH. ORIGINAL DATE OF SURGERY WAS (B)(6) 2010.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD REVISION SURGERY OF A LEFT TOTAL KNEE ARTHROPLASTY. THERE WAS EITHER DISASSOCIATION BETWEEN THE CEMENT AND BASEPLATE OR CEMENT FAILURE WITH BASEPLATE, NECESSITATING RE-OPERATION TO REPLACE BOTH. ORIGINAL DATE OF SURGERY WAS (B)(6) 2010.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
105826 SIMPLEX P FULL DOSE 1 PACK IMPLANT LOD STRYKER ORTHOPAEDICS-MAHWAH RFQ132

Patients

Seq Age Sex Outcome Treatment
1 58 YR Required Intervention